C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
11/2006
11/16/2006	US20060258627 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; Aids therapy
11/15/2006	EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006	EP1517997A4 Luminogenic protease substrates
11/15/2006	EP1416927B1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
11/15/2006	CN1863805A Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
11/15/2006	CN1861610A Synthesizing of Demethylcantharidin-neodymium
11/15/2006	CN1861605A Fleshy glossy ganoderma lactone A, preparation process and use thereof
11/09/2006	WO2006117383A1 Terrylene and quaterrylene derivatives
11/09/2006	WO2006116905A1 Medicinal compounds as antagonists of the platelet- activating factor receptor
11/09/2006	WO2006019673A3 Jiadifenin analogs and uses thereof
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	DE102005021362A1 Terrylen- und Quaterrylenderivate Terrylene- and quaterrylene
11/09/2006	DE102005020494A1 Verfahren zur Herstellung von Tetracarbonsäuren A process for preparing tetracarboxylic acids
11/08/2006	EP1719512A2 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
11/08/2006	EP1419155B1 Piperidine derivatives as antibacterial agents
11/07/2006	US7132252 Comprises fluorophores selected from 7-hydroxycoumarin derivtives, resorufin, and a fluorescein; drug screening
11/07/2006	US7132215 Ester compounds, polymers, resist compositions and patterning process
11/07/2006	CA2191664C Formulation for iron chelation, a process for preparing the formulation and a method of treating thalassemia
11/02/2006	WO2006067224A3 Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247246 3-{[(5,5a,8a,9)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]amino}-1-methyl-1H-pyrrole-2,5-dione; anticarcinogenic agent; inhibiting catalytic activity of topoisomerase II by stabilization of cleavable complex; better soluble and tolerated
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	EP1716222A1 Perfuming ingredients capable of imparting woody odors
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1222184B1 Preparation and use of gamma-butyrolactones as cross-linking agents
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
10/2006
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
10/31/2006	US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives
10/26/2006	WO2006112742A2 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES
10/26/2006	WO2006112686A1 Novel lignan compounds, their preparation methods and their uses
10/26/2006	WO2006112442A1 Benzimidazole compound
10/26/2006	WO2006111858A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/26/2006	WO2006036941A3 Specific kinase inhibitors
10/26/2006	WO2005100363A8 (poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents
10/26/2006	US20060241014 Perfuming ingredients capable of imparting woody odors
10/26/2006	US20060240222 Pellicle and novel fluoropolymer
10/26/2006	CA2602610A1 Benzimidazole compound
10/25/2006	EP1714967A1 Antiparasitic artemisinin derivatives
10/25/2006	EP1416949B1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
10/25/2006	EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/25/2006	EP1089998B1 Epothilone derivatives and their synthesis and use
10/25/2006	CN1852883A Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
10/25/2006	CN1850826A Eremophil dilactone natural product with tumour cell growth inhibiting activity
10/25/2006	CN1850825A Eremophil dilactone with tumour cell growth inhibiting activity and its use
10/25/2006	CN1849882A Method for producing podophyllotoxin induced from sino podophyllum hexandrum callus
10/24/2006	US7126015 Converting 2,3-O-isoproylideneglyceralde-hyde compound to a nitromethane derivative; transforming nitromethane derivative into a tetrahydrofuran derivative; intramolecular cyclisation to produce hexahydro-furo[2,3-b]furan-3-ol compound
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization
10/24/2006	US7125854 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
10/24/2006	US7125725 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235052 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses
10/19/2006	US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/19/2006	US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration
10/19/2006	US20060234949 Adduct of topiramate and tramadol hydrochloride and uses thereof
10/19/2006	US20060234160 Novel ester compounds, polymers, resist compositions and patterning process
10/19/2006	US20060234143 Combining a substituted or unsubstituted indoline with a substituted or unsubstituted 3',6-dichlorofluoran;isolating substituted or unsubstituted 3'-chloro-6'-indolinofluoran combining substituted with a substituted or unsubstituted aniline
10/18/2006	EP1712541A1 Method of preparing monoesters of polyhydroxyl alcohols
10/18/2006	EP1534255A4 Processes for preparing 1,3-dioxolane nucleosides
10/18/2006	EP1260510B1 Fluorescent probes for the quantitation of zinc
10/18/2006	CN1849313A 抗生素化合物 Antibiotic compounds
10/18/2006	CN1847237A Ginkgo leaf extract and production process of separating high purity effective component of the extract
10/18/2006	CN1280272C Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/18/2006	CN1280271C Arylphenyl-substituted cyclic keto-enols
10/18/2006	CN1280258C Process for producing 4,5-diamino shikimic acid derivative
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/17/2006	US7122661 treatment with an ion-exchanging means; subsequent decoloration treatment; for isohexide compositions, in particular isosorbide or isomannide.
10/17/2006	CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/12/2006	WO2006107644A1 Colorant compounds, intermediates, and compositions
10/12/2006	WO2005121114A3 1,5 and 1,4-anhydroketoses, methods for the preparation of 1,5-and 1,4-anhydroketoses, intermediates, and uses of 1,5-and 1,4-anhydroketoses
10/12/2006	US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
10/12/2006	US20060228557 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
10/11/2006	EP1709037A2 Hiv protease inhibiting sulfonamides
10/11/2006	CN1844140A Process for synthesizing artificial antigen of ciguatoxin
10/11/2006	CN1844125A Method for extracting bilobalide B from ginkgo leaf or ginkgo leaf extract
10/11/2006	CN1844124A Fluorescent probe for detecting hydrogen peroxide and its synthesis method and use
10/11/2006	CN1279043C Novel type sugar of C12 high carbon, its derivative, preparation method and application
10/11/2006	CN1278681C Adduct of topiramate and tramadol hydrochloride and uses thereof
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/10/2006	CA2359046C Heterocyclically anellated indenochromene derivatives
10/10/2006	CA2291233C Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
10/06/2006	CA2560740A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
10/05/2006	WO2006104897A2 Cytoskeletal active compounds, composition and use
10/05/2006	WO2006103399A1 Hiv integrase inhibitors
10/05/2006	WO2006103338A1 Method for preparing dianhydrohexitol diester compositions
10/05/2006	WO2006102789A1 Ferula fukanensis extract, the preperation method and the use in producing medicine thereof
10/05/2006	WO2006014483A3 Epoxidized esters of vegetable oil fatty acids as reactive diluents
10/05/2006	US20060223993 Colorant compounds, intermediates, and compositions
10/05/2006	US20060223867 administering two or more timed doses of 7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[1-methyl-2-(2-methylsulfanyl-thiazol-4-yl)-vinyl]-4,17-dioxa-bicyclo[14.1.0]heptadecane-5,9-dione also called epothilone b; treating a drug resistant tumor; ovarian cancer
10/05/2006	US20060223819 Quinoline Derivatives as NK-3 Antagonists
10/05/2006	US20060223151 Production of polyketides
10/05/2006	DE112004002032T5 Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung Concentricolid and its derivatives, method for preparing pharmaceutical compositions comprising the use of
10/05/2006	CA2602574A1 Cytoskeletal active compounds, composition and use
10/04/2006	CN1842580A Photochromic compounds
10/04/2006	CN1840532A Dissymmetry diacetals transparent nucleator and its preparation method and use
10/04/2006	CN1839823A Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor

1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 174